September 27, 2021
(Reuters) -Merck & Co is in advanced talks to acquire drugmaker Acceleron Pharma Inc, the Wall Street Journal reported https://ift.tt/3CNVJqj on Monday, citing people familiar with the matter.
Merck and Acceleron did not immediately respond to Reuters’ request for comment.
Cambridge, Massachusetts-based Acceleron focuses on the discovery, development and commercialization of therapeutics to treat blood-related disorders. It had a market capitalization of $10.89 billion, as of its last close.
A Bloomberg report last week said Acceleron was in talks to be acquired for more than $11 billion.
(Reporting by Uday Sampath and Manas Mishra in Bengaluru; Editing by Shinjini Ganguli)
Source Link Merck in advanced talks to buy Acceleron Pharma – WSJ
